Skip to main content
Top
Published in: Journal of Clinical Immunology 7/2021

01-10-2021 | Aztreonam | Letter to Editor

Achromobacter xylosoxidans Pneumonia in a Young Child with Chronic Granulomatous Disease—a Case-Based Review

Authors: Pratap Kumar Patra, Aaqib Zaffar Banday, Rohit Sadanand, Bhawna Sharma, Archana Angrup, Pandiarajan Vignesh, Amit Rawat

Published in: Journal of Clinical Immunology | Issue 7/2021

Login to get access

Excerpt

Chronic granulomatous disease (CGD), an important inborn error of immunity (IEI) affecting phagocytes, is characterized by a defect in the oxidative burst. Chronic or recurrent infections, predominantly due to catalase-positive bacteria and fungi, are the most important clinical phenotype. However, infections due to Achromobacter sp., a group of catalase-positive bacteria, have rarely been reported in CGD. We report a young male child with X-linked CGD who developed persistent pneumonia due to Achromobacter xylosoxidans. Reports of Achromobacter sp. infections in patients with an IEI are sparse. Our report also reviews the characteristics and outcomes of Achromobacter sp. infections in patients with an IEI. In addition to cystic fibrosis, secondary immunodeficiency, and healthcare-associated infections, it seems prudent to consider an IEI whenever A. xylosoxidans is isolated. Timely diagnosis and treatment of A. xylosoxidans infections and the underlying condition are crucial for best therapeutic outcomes. …
Appendix
Available only for authorised users
Literature
1.
go back to reference Dworzack DL, Murray CM, Hodges GR, Barnes WG. Community-acquired bacteremic Achromobacter xylosoxidans type IIIa pneumonia in a patient with idiopathic IgM deficiency. Am J Clin Pathol. 1978 Oct;70(4):712–7.CrossRef Dworzack DL, Murray CM, Hodges GR, Barnes WG. Community-acquired bacteremic Achromobacter xylosoxidans type IIIa pneumonia in a patient with idiopathic IgM deficiency. Am J Clin Pathol. 1978 Oct;70(4):712–7.CrossRef
2.
go back to reference Weitkamp JH, Tang YW, Haas DW, Midha NK, Crowe JE. Recurrent Achromobacter xylosoxidans bacteremia associated with persistent lymph node infection in a patient with hyper-immunoglobulin M syndrome. Clin Infect Dis. 2000 Nov;31(5):1183–7.CrossRef Weitkamp JH, Tang YW, Haas DW, Midha NK, Crowe JE. Recurrent Achromobacter xylosoxidans bacteremia associated with persistent lymph node infection in a patient with hyper-immunoglobulin M syndrome. Clin Infect Dis. 2000 Nov;31(5):1183–7.CrossRef
3.
go back to reference Jaggi P, Freeman AF, Katz BZ. Chronic granulomatous disease presenting with eosinophilic inflammation. Pediatr Infect Dis J. 2005 Nov;24(11):1020–1.CrossRef Jaggi P, Freeman AF, Katz BZ. Chronic granulomatous disease presenting with eosinophilic inflammation. Pediatr Infect Dis J. 2005 Nov;24(11):1020–1.CrossRef
4.
go back to reference Sheehan WJ, Delmonte OM, Miller DT, Roberts AE, Bonilla FA, Morra M, et al. Novel presentation of Omenn syndrome in association with aniridia. J Allergy Clin Immunol. 2009 Apr;123(4):966–9.CrossRef Sheehan WJ, Delmonte OM, Miller DT, Roberts AE, Bonilla FA, Morra M, et al. Novel presentation of Omenn syndrome in association with aniridia. J Allergy Clin Immunol. 2009 Apr;123(4):966–9.CrossRef
5.
go back to reference D’Aversa P, Leo L, Civino A, Monteduro MG, Russo L, Cosi M, et al. A case of chronic otitis caused by Achromobacter xylosoxidans in children with severe combined immunodeficiency (SCID). Microbiologia Medica. 2009 Dec 31;24(4):263–4. D’Aversa P, Leo L, Civino A, Monteduro MG, Russo L, Cosi M, et al. A case of chronic otitis caused by Achromobacter xylosoxidans in children with severe combined immunodeficiency (SCID). Microbiologia Medica. 2009 Dec 31;24(4):263–4.
6.
go back to reference Zegarra-Linares R, Ang JY, Khan F, Asmar BI, McGrath EJ. A teenager patient with recurrent pulmonary abscesses. J Pediatr Infect Dis Soc. 2014 Jun;3(2):e20–3.CrossRef Zegarra-Linares R, Ang JY, Khan F, Asmar BI, McGrath EJ. A teenager patient with recurrent pulmonary abscesses. J Pediatr Infect Dis Soc. 2014 Jun;3(2):e20–3.CrossRef
7.
go back to reference Burns SO, Plagnol V, Gutierrez BM, Al Zahrani D, Curtis J, Gaspar M, et al. Immunodeficiency and disseminated mycobacterial infection associated with homozygous nonsense mutation of IKKβ. J Allergy Clin Immunol. 2014 Jul;134(1):215–8.CrossRef Burns SO, Plagnol V, Gutierrez BM, Al Zahrani D, Curtis J, Gaspar M, et al. Immunodeficiency and disseminated mycobacterial infection associated with homozygous nonsense mutation of IKKβ. J Allergy Clin Immunol. 2014 Jul;134(1):215–8.CrossRef
8.
go back to reference Engelhardt KR, Gertz ME, Keles S, Schäffer AA, Sigmund EC, Glocker C, et al. The extended clinical phenotype of 64 patients with dedicator of cytokinesis 8 deficiency. J Allergy Clin Immunol. 2015 Aug;136(2):402–12.CrossRef Engelhardt KR, Gertz ME, Keles S, Schäffer AA, Sigmund EC, Glocker C, et al. The extended clinical phenotype of 64 patients with dedicator of cytokinesis 8 deficiency. J Allergy Clin Immunol. 2015 Aug;136(2):402–12.CrossRef
9.
go back to reference Duraisingham SS, Manson A, Grigoriadou S, Buckland M, Tong CY, Longhurst HJ. Immune deficiency: changing spectrum of pathogens. Clin Exp Immunol. 2015 Aug;181(2):267–74.CrossRef Duraisingham SS, Manson A, Grigoriadou S, Buckland M, Tong CY, Longhurst HJ. Immune deficiency: changing spectrum of pathogens. Clin Exp Immunol. 2015 Aug;181(2):267–74.CrossRef
10.
go back to reference Mwangi JK, Powers B, Stoeckel D. D32 interesting cases in allergy and immunology: bronchiectasis due to selective immunoglobulin M deficiency. Am J Respir Crit Care Med. 2015;191:1.CrossRef Mwangi JK, Powers B, Stoeckel D. D32 interesting cases in allergy and immunology: bronchiectasis due to selective immunoglobulin M deficiency. Am J Respir Crit Care Med. 2015;191:1.CrossRef
11.
go back to reference Singh A, Hussain A, Jain R, Aishwarya K, Tak V, Thakur P. Achromobacter xylosoxidans septic arthritis in a child with primary immunodeficiency. J Global Infect Dis. 2017 Mar;9(1):36–7.CrossRef Singh A, Hussain A, Jain R, Aishwarya K, Tak V, Thakur P. Achromobacter xylosoxidans septic arthritis in a child with primary immunodeficiency. J Global Infect Dis. 2017 Mar;9(1):36–7.CrossRef
12.
go back to reference Özışık L, Cebrayilov C, Başaran NÇ, Güven GS. Hepatic granuloma mimicking tuberculosis: Achromobacter xylosoxidans in a patient with familial Mediterranean fever. Acta Med Austriaca. 2017 Mar 31;48(1):37–40. Özışık L, Cebrayilov C, Başaran NÇ, Güven GS. Hepatic granuloma mimicking tuberculosis: Achromobacter xylosoxidans in a patient with familial Mediterranean fever. Acta Med Austriaca. 2017 Mar 31;48(1):37–40.
13.
go back to reference McCormack RM, Szymanski EP, Hsu AP, Perez E, Olivier KN, Fisher E, et al. MPEG1/perforin-2 mutations in human pulmonary nontuberculous mycobacterial infections. JCI Insight. 2017 Apr;20:2(8). McCormack RM, Szymanski EP, Hsu AP, Perez E, Olivier KN, Fisher E, et al. MPEG1/perforin-2 mutations in human pulmonary nontuberculous mycobacterial infections. JCI Insight. 2017 Apr;20:2(8).
14.
go back to reference Janarthanan M, Gollapalli S, Sankaranarayanan S. Achromobacter xylosoxidans sepsis unveiling X-linked agammaglobulinemia masquerading as systemic-onset juvenile idiopathic arthritis. Indian Pediatr. 2019 May 15;56(5):423–5.CrossRef Janarthanan M, Gollapalli S, Sankaranarayanan S. Achromobacter xylosoxidans sepsis unveiling X-linked agammaglobulinemia masquerading as systemic-onset juvenile idiopathic arthritis. Indian Pediatr. 2019 May 15;56(5):423–5.CrossRef
15.
go back to reference Więsik-Szewczyk E, Jahnz-Różyk K. From infections to autoimmunity: diagnostic challenges in common variable immunodeficiency. World J Clin Cases. 2020 Sep 26;8(18):3942–55.CrossRef Więsik-Szewczyk E, Jahnz-Różyk K. From infections to autoimmunity: diagnostic challenges in common variable immunodeficiency. World J Clin Cases. 2020 Sep 26;8(18):3942–55.CrossRef
16.
go back to reference Więsik-Szewczyk E, Ziętkiewicz M, Matyja-Bednarczyk A, Napiórkowska-Baran K, Suchanek H, Jahnz-Różyk K. The first polish cohort of adult patients with common variable immunodeficiency from 4 specialized centers: do we provide standards of care? Pol Arch Intern Med. 2018 Sep 28;128(9):563–6.PubMed Więsik-Szewczyk E, Ziętkiewicz M, Matyja-Bednarczyk A, Napiórkowska-Baran K, Suchanek H, Jahnz-Różyk K. The first polish cohort of adult patients with common variable immunodeficiency from 4 specialized centers: do we provide standards of care? Pol Arch Intern Med. 2018 Sep 28;128(9):563–6.PubMed
17.
go back to reference Lu HY, Sharma M, Biggs CM, Huang YH, Shopsowitz KE, Frosk P, et al. The importance of functional validation after next-generation sequencing: evaluation of a novel CARD11 variant. Pediatr Allergy Immunol. 2018 Sep;29(6):663–8.CrossRef Lu HY, Sharma M, Biggs CM, Huang YH, Shopsowitz KE, Frosk P, et al. The importance of functional validation after next-generation sequencing: evaluation of a novel CARD11 variant. Pediatr Allergy Immunol. 2018 Sep;29(6):663–8.CrossRef
18.
go back to reference Xie M, Lee J, Crespo M, Fajt ML, Shigemura N, Pilewski JM, et al. Successful lung transplantation in a patient with chronic granulomatous disease. J Clin Immunol. 2019 May;39(4):347–9.CrossRef Xie M, Lee J, Crespo M, Fajt ML, Shigemura N, Pilewski JM, et al. Successful lung transplantation in a patient with chronic granulomatous disease. J Clin Immunol. 2019 May;39(4):347–9.CrossRef
19.
go back to reference Rawat A, Jindal AK, Suri D, Vignesh P, Gupta A, Saikia B, et al. Clinical and genetic profile of X-linked agammaglobulinemia: a multicenter experience from India. Front Immunol. 2020;11:612323.CrossRef Rawat A, Jindal AK, Suri D, Vignesh P, Gupta A, Saikia B, et al. Clinical and genetic profile of X-linked agammaglobulinemia: a multicenter experience from India. Front Immunol. 2020;11:612323.CrossRef
20.
go back to reference Leusen JH, de Boer M, Bolscher BG, Hilarius PM, Weening RS, Ochs HD, et al. A point mutation in gp91-phox of cytochrome b558 of the human NADPH oxidase leading to defective translocation of the cytosolic proteins p47-phox and p67-phox. J Clin Invest. 1994 May;93(5):2120–6.CrossRef Leusen JH, de Boer M, Bolscher BG, Hilarius PM, Weening RS, Ochs HD, et al. A point mutation in gp91-phox of cytochrome b558 of the human NADPH oxidase leading to defective translocation of the cytosolic proteins p47-phox and p67-phox. J Clin Invest. 1994 May;93(5):2120–6.CrossRef
22.
go back to reference Wu J, Wang WF, Zhang YD, Chen TX. Clinical features and genetic analysis of 48 patients with chronic granulomatous disease in a single center study from Shanghai, China (2005-2015): new studies and a literature review. J Immunol Res. 2017;2017:8745254.PubMedPubMedCentral Wu J, Wang WF, Zhang YD, Chen TX. Clinical features and genetic analysis of 48 patients with chronic granulomatous disease in a single center study from Shanghai, China (2005-2015): new studies and a literature review. J Immunol Res. 2017;2017:8745254.PubMedPubMedCentral
23.
go back to reference Spear JB, Fuhrer J, Kirby BD. Achromobacter xylosoxidans (Alcaligenes xylosoxidans subsp. xylosoxidans) bacteremia associated with a well-water source: case report and review of the literature. J Clin Microbiol. 1988 Mar;26(3):598–9.CrossRef Spear JB, Fuhrer J, Kirby BD. Achromobacter xylosoxidans (Alcaligenes xylosoxidans subsp. xylosoxidans) bacteremia associated with a well-water source: case report and review of the literature. J Clin Microbiol. 1988 Mar;26(3):598–9.CrossRef
24.
go back to reference Kowalczyk A, Chyc M, Ryszka P, Latowski D. Achromobacter xylosoxidans as a new microorganism strain colonizing high-density polyethylene as a key step to its biodegradation. Environ Sci Pollut Res Int. 2016 Jun;23(11):11349–56.CrossRef Kowalczyk A, Chyc M, Ryszka P, Latowski D. Achromobacter xylosoxidans as a new microorganism strain colonizing high-density polyethylene as a key step to its biodegradation. Environ Sci Pollut Res Int. 2016 Jun;23(11):11349–56.CrossRef
25.
go back to reference Igra-Siegman Y, Chmel H, Cobbs C. Clinical and laboratory characteristics of Achromobacter xylosoxidans infection. J Clin Microbiol. 1980 Feb;11(2):141–5.CrossRef Igra-Siegman Y, Chmel H, Cobbs C. Clinical and laboratory characteristics of Achromobacter xylosoxidans infection. J Clin Microbiol. 1980 Feb;11(2):141–5.CrossRef
26.
go back to reference Gómez-Cerezo J, Suárez I, Ríos JJ, Peña P, García de Miguel MJ, de José M, et al. Achromobacter xylosoxidans bacteremia: a 10-year analysis of 54 cases. Eur J Clin Microbiol Infect Dis. 2003 Jun;22(6):360–3.CrossRef Gómez-Cerezo J, Suárez I, Ríos JJ, Peña P, García de Miguel MJ, de José M, et al. Achromobacter xylosoxidans bacteremia: a 10-year analysis of 54 cases. Eur J Clin Microbiol Infect Dis. 2003 Jun;22(6):360–3.CrossRef
27.
go back to reference Tatro ET, Purnajo I, Richman DD, Smith DM, Gianella S. Antibody response to Achromobacter xylosoxidans during HIV infection is associated with lower CD4 levels and increased lymphocyte activation. Clin Vaccine Immunol. 2014 Jan;21(1):46–50.CrossRef Tatro ET, Purnajo I, Richman DD, Smith DM, Gianella S. Antibody response to Achromobacter xylosoxidans during HIV infection is associated with lower CD4 levels and increased lymphocyte activation. Clin Vaccine Immunol. 2014 Jan;21(1):46–50.CrossRef
28.
go back to reference De Baets F, Schelstraete P, Van Daele S, Haerynck F, Vaneechoutte M. Achromobacter xylosoxidans in cystic fibrosis: prevalence and clinical relevance. J Cyst Fibros. 2007 Jan;6(1):75–8.CrossRef De Baets F, Schelstraete P, Van Daele S, Haerynck F, Vaneechoutte M. Achromobacter xylosoxidans in cystic fibrosis: prevalence and clinical relevance. J Cyst Fibros. 2007 Jan;6(1):75–8.CrossRef
29.
go back to reference Legrand C, Anaissie E. Bacteremia due to Achromobacter xylosoxidans in patients with cancer. Clin Infect Dis. 1992 Feb 1;14(2):479–84.CrossRef Legrand C, Anaissie E. Bacteremia due to Achromobacter xylosoxidans in patients with cancer. Clin Infect Dis. 1992 Feb 1;14(2):479–84.CrossRef
Metadata
Title
Achromobacter xylosoxidans Pneumonia in a Young Child with Chronic Granulomatous Disease—a Case-Based Review
Authors
Pratap Kumar Patra
Aaqib Zaffar Banday
Rohit Sadanand
Bhawna Sharma
Archana Angrup
Pandiarajan Vignesh
Amit Rawat
Publication date
01-10-2021
Publisher
Springer US
Published in
Journal of Clinical Immunology / Issue 7/2021
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-021-01079-3

Other articles of this Issue 7/2021

Journal of Clinical Immunology 7/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.